Proteome-based Personalized Immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Proteome-based Personalized Immunotherapy, covering 2017-10-12 to 2017-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Proteome-based Personalized Immunotherapy of Glioblastoma [Phase 2, Phase 3]